Vivoryon Therapeutics (Netherlands) Probability of Future Stock Price Finishing Under 1.99
Vivoryon Therapeutics' future price is the expected price of Vivoryon Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vivoryon Therapeutics NV performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please specify Vivoryon Therapeutics' target price for which you would like Vivoryon Therapeutics odds to be computed.
Vivoryon |
Vivoryon Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vivoryon Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vivoryon Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vivoryon Therapeutics is not yet fully synchronised with the market data | |
| Vivoryon Therapeutics has some characteristics of a very speculative penny stock | |
| Vivoryon Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 10.76 M. Net Loss for the year was (12.65 M) with profit before overhead, payroll, taxes, and interest of 9.2 M. | |
| Vivoryon Therapeutics generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by insiders |
Vivoryon Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vivoryon Stock often depends not only on the future outlook of the current and potential Vivoryon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vivoryon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.1 M |
Vivoryon Therapeutics Technical Analysis
Vivoryon Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Vivoryon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vivoryon Therapeutics NV. In general, you should focus on analyzing Vivoryon Stock price patterns and their correlations with different microeconomic environments and drivers.
Vivoryon Therapeutics Predictive Forecast Models
Vivoryon Therapeutics' time-series forecasting models is one of many Vivoryon Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vivoryon Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vivoryon Therapeutics
Checking the ongoing alerts about Vivoryon Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vivoryon Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vivoryon Therapeutics generated a negative expected return over the last 90 days | |
| Vivoryon Therapeutics has high historical volatility and very poor performance | |
| Vivoryon Therapeutics may become a speculative penny stock | |
| Vivoryon Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 10.76 M. Net Loss for the year was (12.65 M) with profit before overhead, payroll, taxes, and interest of 9.2 M. | |
| Vivoryon Therapeutics generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by insiders |
Additional Tools for Vivoryon Stock Analysis
When running Vivoryon Therapeutics' price analysis, check to measure Vivoryon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivoryon Therapeutics is operating at the current time. Most of Vivoryon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivoryon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivoryon Therapeutics' price. Additionally, you may evaluate how the addition of Vivoryon Therapeutics to your portfolios can decrease your overall portfolio volatility.